A benign Becker muscular dystrophy (BMD)patient with a marked decrease in dystrophin exhibited remarkable expression of dystrophin-related protein (DRP) on most of the muscle cell membrane. A phenotypic Duchenne muscular dystrophy patient with a truncated form of dystrophin exhibited no DRPexpression on the muscle cell membrane except for the neuromuscular junction. Increased DRPexpression might compensate for a lack of dystrophin in some BMDpatients. (Internal Medicine 33: 334-336, 1994) 
Introduction
Dystrophin-related protein (DRP) (1) is a 13-kilobase transcript that mapsto humanchromosome6 and exhibits entire length homology to dystrophin (2) . Its localization in normal skeletal muscle is similar to that of acetylcholine receptor (3) . On the other hand, DRPexpression is increased on most of the muscle cell membrane in Duchenne muscular dystrophy (DMD) (4, 5) . In Becker muscular dystrophy (BMD), some regenerating fibers show a positive immunoreaction to DRPon the muscle cell membrane (6) . However, it remains to be determined whether or not DRPcan functionally compensate for a dystrophin abnormality. Here we report a benign BMDpatient and a phenotypic DMDpatient exhibiting an unusual immunoreactionto anti-DRP antibody.
Patients and Methods
Patient 1 was a 42-year-old man who gradually developed progressive muscle weakness in childhood. He could not run at age 15 years and noticed difficulty in standing up from the floor at age 42 years. He had proximal dominant muscle weakness and hypertrophy of the calves. Serum CKactivity was elevated to 302 U/L (normal: less than 55 U/L). He had no family history of neuro-muscular diseases. Patient 2 was a 13-year-old boy whohad rapidly progressive muscle weakness and became wheelchair-bound at age 10 years. Wereported the results of dystrophin tests for this patient previously (7) . Biopsied specimens were obtained from the biceps brachii muscle of both patients.
Serial frozen sections of the specimenswere stained by means of standard histologic and histochemical techniques. Immunohistochemical studies were performed according to the avidin-biotin complex (ABC) method (8) . Weused 3 types of monoclonal antibodies which were raised against the N-terminus, mid rod and C-terminus of dystrophin (purchased from Novocastra, England) , and anti-DRP polyclonal antibody (provided by Dr. S. Ishiura, Tokyo University), which exhibits no cross-reactivity to the dystrophin molecule (3). Immunoblot analysis was performed by the method described by Hoffmanet al (9) . Blood samples were used for DNAstudies performed by SRL (Tokyo, Japan) using the multiplex polymerase chain reaction (PCR) method. Oligonucleotide primer sequences that can be used to amplify a muscle specific promoter and 1 8 exons patchy staining pattern (Fig. 1A) . Immunohistochemical staining for DRPin patient 1 disclosed continuous marked expression of DRPon most of the muscle cell membrane (Fig. IB) .
Immunohistochemical studies for dystrophin in patient 2 disclosed a patchy staining pattern with the antibodies against the C-terminus (Fig. 1C) and the mid rod domain of dystrophin, however, no immunoreaction was observed with the N-terminal antibody. Immunohistochemical staining for DRPin patient 2 showed no DRPexpression on the muscle cell membrane except for the neuro-muscularjunction (Fig. ID) . Immunoblot testing of patient 1 revealed an almost normal molecular weight and a markedly reduced amount of dystrophin. That of patient 2 revealed an abnormal molecular weight (340 kd) and a wellpreserved amount of dystrophin with the C-terminal antibody; no immunoreaction was observed with the N-terminal antibody (7) . Multiplex PCRanalysis demonstrated the deletion ofexons 3 and4inpatient 1, andexons 3,4, 6, 8, 12, 13, 17, and 19in natient?
Most muscle fibers in DMDpatients show DRPexpression on the cell membrane,and selective DRPexpression on regenerating muscle fibers is the most commonfinding in BMD patients (6) . However, we demonstrated marked continuous expression of DRPon the cell membranenot only in regenerating but also in normal appearing muscle fibers in patient 1. The patient was diagnosed as having BMD,and the clinical course seems to be benign (he can walk at age 42) in spite of the marked decrease in the amount of dystrophin. Onthe contrary, the muscle fibers in patient 2 showed no DRPexpression on the muscle cell membraneexcept for the neuro-muscular junction.
He had rapidly progressive muscle weaknessand was clinically diagnosed as having DMD,however, he was later diagnosed as having BMDon the basis of dystrophin test results. As an explanation of the unusual severity in this patient, we previously reported that deletion of the N-terminal domain of dystrophin can cause a severe phenotype. The abnormality of DRPexpression on the muscle cell membranemight have also 
